SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-23-001721
Filing Date
2023-12-08
Accepted
2023-12-08 16:31:39
Documents
16
Period of Report
2023-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nhwk_8k.htm   iXBRL 8-K 36066
2 SALES AGREEMENT WITH A.G.P./ALLIANCE DATED DECEMBER 8, 2023 ex1x1.htm EX-1.1 238993
3 LEGAL OPINION ex5x1.htm EX-5.1 11448
4 GRAPHIC image_001.jpg GRAPHIC 7525
  Complete submission text file 0001079973-23-001721.txt   579123

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE nhwk-20231208.xsd EX-101.SCH 3534
6 XBRL DEFINITION FILE nhwk-20231208_def.xml EX-101.DEF 26569
7 XBRL LABEL FILE nhwk-20231208_lab.xml EX-101.LAB 36527
8 XBRL PRESENTATION FILE nhwk-20231208_pre.xml EX-101.PRE 25193
10 EXTRACTED XBRL INSTANCE DOCUMENT nhwk_8k_htm.xml XML 5025
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 231475858
SIC: 2834 Pharmaceutical Preparations